Category: Health & Medicines > Health Care Supplement
Country/Region: China
Main Products: Ritonavir Intermediate, Lamivudine Intermediate, Fluvastatin Intermediate, Terbinafine Intermediate, Nelfinavir Intermediate, Tenofovir Intermediate, Aliskiren Intermediate, Celecoxib Intermediate, Fluoxetine Intermediate, Mefloquine Intermediate, Ritonavir Intermediate
Business Type: Manufacturer
Business Nature: Manufacturer
Year Established: 2012, 2012
Legal Status: Third Party
Ownership: LLC
Employees: 201 - 300 People
Factory Size: 3, 000-5, 000 square meters
R&D Team Size: 5 - 10 People
Certifications: ISO17025
Contact Person: Yuan Sunny
Designation: Account Manager
Department: Director
Telephone: 86-15961049579
Main Markets: Malaysia (19%) Australia (13%) Israel (12%) Philippines (12%) Singapore (10%)
Export Focus: Australia, Israel, Malaysia, Philippines, Singapore
Contract Services: OEM Service Offered
Annual Revenue: More than 6 Million US Dollar
Registered Capital: Above US$100 Million
Export Percentage: 41% - 50%
Payment Terms: Bank wire (T/T), MoneyGram, Credit Card (CC), PayPal